Binding analysis of nilvadipine to plasma lipoproteins by capillary electrophoresis-frontal analysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 21, Issue 5, 1999, Pages 1037-1043

  Mohamed, Niveen Abdel Latif ^b   Kuroda, Yukihiro ^a   Shibukawa, Akimasa ^a   Nakagawa, Terumichi ^a   El Gizawy, Samia ^b   Askal, Hassan F ^b   El Kommos, Micheal E ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Assiut University   (Egypt)

Author keywords

Capillary electrophoresis; Frontal analysis; Lipoprotein; Nilvadipine; Protein binding

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NILVADIPINE;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG SELECTIVITY; ENANTIOMER; HUMAN; PRIORITY JOURNAL; SURFACE CHARGE;

BINDING, COMPETITIVE; CALCIUM CHANNEL BLOCKERS; ELECTROPHORESIS, CAPILLARY; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; NIFEDIPINE; PROTEIN BINDING; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032717435     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00197-1     Document Type: Article

References (25)

1. Meyer M.C., Guttman D.E. J. Pharm. Sci. 57:1968;895-918.
2. Vallner J.J. J. Pharm. Sci. 66:1977;447-465.
3. Kwong T.C. Clin. Chim. Acta. 151:1985;193-216.
4. Urien S. Tillement J.P., Lindenlaub E. Protein Binding and Drug Transport. 1986;63-75 F.K. Schattauer, Stuttgart.
5. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. N. Engl. J. Med. 320:1989;915-924.
6. Witztum J.L., Steinberg D. J. Clin. Invest. 88:1991;1785-1792.
7. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Proc. Natl. Acad. Sci. 84:1987;2995-2998.
8. Quinn M.T., Parthasarathy S., Steinberg D. Proc. Natl. Acad. Sci. 82:1985;5949-5953.
9. Tucker G.T., Lennard M.S. Pharmacol. Ther. 45:1989;309-329.
10. Noctor T. Wainer I.W. Drug Stereochemistry. 2nd edn:1993;Marcel Dekker, New York.
11. Shibukawa A., Yoshimoto Y., Ohara T., Nakagawa T. J. Pharm. Sci. 83:1994;616-619.
12. Ohara T., Shibukawa A., Nakagawa T. Anal. Chem. 67:1995;3520-3525.
13. Shiono H., Shibukawa A., Kuroda Y., Nakagawa T. Chirality. 9:1997;291-296.
14. Kuroda Y., Shibukawa A., Nakagawa T. Anal. Biochem. 268:1999;9-14.
15. Niwa T., Tokuma Y., Noguchi H. Res. Commun. Chem. Pathol. Pharmacol. 55:1987;75-88.
16. Yoshida H., Ayaori M., Suzukawa M., Hosoai H., Nioshiwaki M., Ishikawa T., Nakamura H. Hypertens. Res. 18:1995;47-53.
17. Auerbach B.J., Bisgaier C.L., Wolle J., Saxena U. J. Biol. Chem. 271:1996;1329-1335.
18. Maeba R., Shimasaki H., Ueta N. Biochim. Biophys. Acta. 1215:1994;79-86.
19. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. Anal. Biochem. 81:1978;206-210.
20. Busch M.H.A., Carels L.B., Boelens H.F.M., Kraak J.C., Poppe H. J. Chromatogr. A. 777:1997;311-328.
21. Busch M.H.A., Kraak J.C., Poppe H. J. Chromatogr. A. 777:1997;329-353.
22. Kostner G.M., Laggner P. Fruchart J.C., Shepherd J. Human Plasma Lipoproteins. 1989;23-54 Walter de Gruyter, Berlin.
23. Mahley R.W., Innerarity T.L., Rall S.C. Jr, Weisgraber K.H. J. Lipid Res. 25:1984;1277-1294.
24. Thomas C.E., Jackson R.L. J. Pharmacol. Exp. Ther. 256:1991;1182-1188.
25. Steinbrecher U.P. J. Biol. Chem. 262:1987;3603-3608.